Details of Drug

Drug General Information (ID: D0487)
Drug Name	Diethylstilbestrol
Drug Type	Small molecule
Drug Synonymous	Acnestrol; Agostilben; Antigestil; Apstil; Bufon; Climaterine; Comestrol; Cyren; DES; Desma; Destrol; Diaethylstilboestrolum; Diastyl; Dibestrol; Dicorvin; Diethylstilbesterol; Diethylstilbestrolum; Diethylstilboesterol; Dietilestilbestrol; Dietilstilbestrolo; Distilbene; Domestrol; Dyestrol; Estril; Estrobene; Estrogenine; Estromenin; Estrosyn; Fonatol; Grafestrol; Gynopharm; Hibestrol; Idroestril; Iscovesco; Makarol; Menostilbeen; Micrest; Microest; Milestrol; OeKolp; Oestrogenine; Oestrolmensil; Oestromenin; Oestromensil; Oestromensyl; Oestromienin; Oestromon; Pabestrol; Palestrol; Protectona; Sedestran; Serral; Sexocretin; Sibol; Sintestrol; Stibilium; Stilbestroform; Stilbestrol; Stilbestrone; Stilbetin; Stilboefral; Stilboestroform; Stilboestrol; Stilbofolin; Stilbofollin; Stilbol; Stilkap; Strobene; Synestrin; Synthestrin; Synthoestrin; Synthofolin; Syntofolin; Tampovagan; Tylosterone; Vagestrol; APS Brand of Diethylstilbestrol; Anti gestil; Co Pharma Brand of Diethylstilbestrol; Comestrol estrobene; Cyren A; Diethylstilbestrol BP; Dietilestilbestrol [Spanish]; Dietilstilbestrolo [DCIT]; Estilbin MCO; Gerda Brand of Diethylstilbestrol; Oestrol vetag; Percutatrine oestrogenique iscovesco; ST IL; Stilbene Estrogen; Tampovagan stilboestrol; DiBestrol 2 Premix; MG 137; Rumestrol 1; Rumestrol 2; Cis-Des; Cis-Diethylstilbesterol; Cis-Diethylstilbestrol; Co-Pharma Brand of Diethylstilbestrol; DES (synthetic estrogen); Dawe's destrol; Di-Estryl; Diethylstilbestrol (DES); Diethylstilbestrol [USAN:INN]; Diethylstilbestrol, Disodium Salt; Diethylstilbestrolum [INN-Latin]; Dietilestilbestrol [INN-Spanish]; E-Diethylstilbestrol; Estilbin (MCO); Estrogen, Stilbene; Hi-Bestrol; Neo-Oestranol 1; Neo-Oestranol I; Neo-oe stranol 1; New-Estranol 1; Stil-Rol; Stilbestrol (TN); TRANS-DIETHYSTILBESTEROL; TRANSGENIC MODEL EVALUATION (DES); Trans-Diethylstilbesterol; Trans-Diethylstilbestrol; Trans-Diethylstilboesterol; DiBestrol "2" Premix; Dibestrol '2' premix; Diethylstilbestrol (USP/INN); Alpha,alpha'-Diethylstilbenediol; Diethylstilbestrol, (Z)-Isomer; Alpha,alpha'-Diethyl-4,4'-stilbenediol; (E)-3,4-Bis(4-hydroxyphenyl)-3-hexene; (E)-4,4'-(hex-3-ene-3,4-diyl)diphenol; (E)-Diethylstilbestrol; 3,4'(4,4'-Dihydroxyphenyl)hex-3-ene; 3,4-Bis(p-hydroxyphenyl)-3-hexene; 3,4-bis(4-hydroxyphenyl)hex-3-ene; 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol; 4,4'-Dihydroxydiethylstilbene; 4,4'-hex-3-ene-3,4-diyldiphenol Click to Show/Hide
Disease Class	GA02: Vaginitis
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C18H20O2
InChI	1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+
InChIKey	RGLYKWWBQGJZGM-ISLYRVAYSA-N
Canonical SMILES	CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O
External Link
	Pubchem ID	448537
	CAS Number	56-53-1
	CHEBI ID	41922
	TTD ID	D0Y2NE
	INTEDE ID	DR0492
	VARIDT ID	DR00922

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM015 Increase globulin concentration BM017 CYP450 enzyme inhibition BM019 UGT inhibition BM022 CYP450 enzyme induction BM023 UGT induction BM025 Decreased metabolism (Unspecific) BM047 Additive thrombogenic effects BM055 Increased risk of hepatotoxicity BM085 Antagonize the effect of antithrombotic agents BM086 Antagonize the effect of antidiabetic agents BM089 Antagonize the effect of antihypertensive agents BM094 Antagonize the effect of estrogen BM107 Attenuated pharmacological effects (Unspecific) BM108 Increased risk of hypercalcemia BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Diethylstilbestrol
Affected gastrointestinal absorption
	Complex formation					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0329		Cholestyramine	C27H47ClN2	137699107	Moderate		Inter Info	[30], [31], [3], [32], [33], [34], [35]
D0382		Colestipol	C11H28ClN5O	62816	Moderate		Inter Info	[30], [31], [3], [32], [33], [34], [35]
Affected organization distribution
	Increase globulin concentration					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0172		Betamethasone	C22H29FO5	9782	Moderate		Inter Info	[27], [28], [29]
D0215		Budesonide	C25H34O6	5281004	Moderate		Inter Info	[27], [28], [29]
D0392		Corticotropin	C207H308N56O58S	16132265	Moderate		Inter Info	[27], [28], [29]
D0436		Deflazacort	C25H31NO6	189821	Moderate		Inter Info	[27], [28], [29]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[27], [28], [29]
D0671		Fludrocortisone	C21H29FO5	31378	Moderate		Inter Info	[27], [28], [29]
D0773		Hydrocortisone	C21H30O5	5754	Moderate		Inter Info	[27], [28], [29]
D0925		Levothyroxine	C15H11I4NO4	5819	Moderate		Inter Info	[60], [61], [62], [33], [63], [64]
D0934		Liothyronine	C15H12I3NO4	5920	Moderate		Inter Info	[60], [61], [62], [33], [63], [64]
D0935		Liotrix	C30H21I7N2Na2O8	71371	Moderate		Inter Info	[60], [63], [64]
D1041		Methylprednisolone	C22H30O5	6741	Moderate		Inter Info	[27], [28], [29]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[27], [28], [29]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[27], [28], [29]
D1563		Tetracosactide	C136H210N40O31S	16133802	Moderate		Inter Info	[27], [28], [29]
D1577		Thyroid, porcine	NA	NA	Moderate		Inter Info	[60], [63], [64]
D1628		Triamcinolone	C21H27FO6	31307	Moderate		Inter Info	[27], [28], [29]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[27], [28], [29]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[25], [26]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[3], [1], [36], [37], [38], [39], [40]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[51]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[25], [26]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[59]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[65]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[68], [69], [70]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[3], [1], [36], [37], [38], [39], [40]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[41], [42], [43], [44], [45], [46]
D0994		Melatonin	C13H16N2O2	896	Minor		Inter Info	[3]
D0799		Indinavir	C36H47N5O4	5362440	Minor		Inter Info	[97]
	UGT inhibition					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1227		Paritaprevir	C40H43N7O7S	45110509	Major		Inter Info	[8], [9]
	CYP450 enzyme induction					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[1], [52]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[1], [66]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[85], [86], [87], [88], [89]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[85], [86], [87], [88], [89]
	UGT induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1677		Valproic acid	C8H16O2	3121	Moderate		Inter Info	[71], [72], [73], [74]
	Decreased metabolism (Unspecific)					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0068		Amitriptyline	C20H23N	2160	Minor		Inter Info	[82], [83], [84]
D0072		Amoxapine	C17H16ClN3O	2170	Minor		Inter Info	[82], [83], [84]
D0337		Cimetidine	C10H16N6S	2756	Minor		Inter Info	[90], [91], [92]
D0361		Clomipramine	C19H23ClN2	2801	Minor		Inter Info	[82], [83], [84]
D0446		Desipramine	C18H22N2	2995	Minor		Inter Info	[82], [83], [84]
D0525		Doxepin	C19H21NO	667477	Minor		Inter Info	[82], [83], [84]
D0795		Imipramine	C19H24N2	3696	Minor		Inter Info	[82], [83], [84]
D1158		Nortriptyline	C19H21N	4543	Minor		Inter Info	[82], [83], [84]
D1361		Protriptyline	C19H21N	4976	Minor		Inter Info	[82], [83], [84]
D1647		Trimipramine	C20H26N2	5584	Minor		Inter Info	[82], [83], [84]
Pharmacodynamic additive effects
	Additive thrombogenic effects					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0261		Carfilzomib	C40H57N5O7	11556711	Major		Inter Info	[3], [4], [1]
D0902		Lenalidomide	C13H13N3O3	216326	Major		Inter Info	[1], [6], [7]
D1312		Pomalidomide	C13H11N3O4	134780	Major		Inter Info	[10], [11], [12]
D1569		Thalidomide	C13H10N2O4	5426	Major		Inter Info	[1], [10], [13]
D1619		Tranexamic acid	C8H15NO2	5526	Major		Inter Info	[14], [15], [16]
D0385		Conestat alfa	NA	NA	Moderate		Inter Info	[47], [48], [49], [50]
D0762		Human C1-esterase inhibitor	NA	NA	Moderate		Inter Info	[47], [49], [50]
	Increased risk of hepatotoxicity					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0417		Dantrolene	C14H10N4O5	6914273	Major		Inter Info	[5]
	Increased risk of hypercalcemia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1754		Calcitriol (topical)	C27H44O3	5280453	Moderate		Inter Info	[17], [18]
D1753		Calcipotriol (topical)	C27H40O3	5288783	Moderate		Inter Info	[17], [18]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[1], [2]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antithrombotic agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[75], [76], [77], [78], [79], [80], [81]
	Antagonize the effect of antidiabetic agents					Drug Num: 34
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[19], [20], [21]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[19], [20], [21]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[19], [20], [21]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[19], [20], [21]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[19], [20], [21]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[19], [20], [21]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[19], [20], [21]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[19], [20], [21]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[19], [20], [21]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[19], [20], [21]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[19], [20], [21]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[19], [20], [21]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[19], [20], [21]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[19], [20], [21]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[19], [20], [21]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[19], [20], [21]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[19], [20], [21]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[19], [20], [21]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[19], [20], [21]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[19], [20], [21]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[19], [20], [21]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[19], [20], [21]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[19], [20], [21]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[19], [20], [21]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[19], [20], [21]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[19], [20], [21]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[19], [20], [21]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[19], [20], [21]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[19], [20], [21]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[19], [20], [21]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[19], [20], [21]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[19], [20], [21]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[19], [20], [21]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[19], [20], [21]
	Antagonize the effect of antihypertensive agents					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1779		Dulaglutide	NA	NA	Moderate		Inter Info	[19], [20], [21]
D1782		Ertugliflozin	C22H25ClO7	44814423	Moderate		Inter Info	[19], [20], [21]
D1784		Exenatide	C184H282N50O60S	45588096	Moderate		Inter Info	[19], [20], [21]
D1887		Semaglutide	C187H291N45O59	56843331	Moderate		Inter Info	[19], [20], [21]
	Antagonize the effect of estrogen					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1885		Saw palmetto	NA	NA	Minor		Inter Info	[96], [54], [55]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0086		Anastrozole	C17H19N5	2187	Moderate		Inter Info	[22], [23], [24]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[53], [54], [55]
D0630		Exemestane	C20H24O2	60198	Moderate		Inter Info	[22], [23], [24]
D0890		Lamotrigine	C9H7Cl2N5	3878	Moderate		Inter Info	[56], [57], [58]
D0907		Letrozole	C17H11N5	3902	Moderate		Inter Info	[22], [23], [24]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[3], [1], [67]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[3], [1], [67]
D1812		Hyaluronidase	C17H24BrNO2	91820602	Minor		Inter Info	[93], [94], [95]

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
3	Cerner Multum, Inc. "Australian Product Information.".
4	Product Information. Kyprolis (carfilzomib). Onyx Pharmaceuticals Inc, South San Francisco, CA.
5	Product Information. Dantrium (dantrolene). Procter and Gamble Pharmaceutic, Cincinnati, OH.
6	Product Information. Revlimid (lenalidomide). Celgene Corporation, Summit, NJ.
7	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
8	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
9	Product Information. Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir). AbbVie US LLC, North Chicago, IL.
10	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
11	Product Information. Pomalyst (pomalidomide). QLT Phototherapeutics Inc, Vancouver, AZ.
12	Therapeutic Research Faculty "Natural Medicines Comprehensive Database."
13	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
14	Product Information. Cyklokapron (tranexamic acid). Pharmacia and Upjohn, Kalamazoo, MI.
15	van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR "The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study." BMJ 339 (2009): b2921.[PMID: 19679614]
16	Gomes MP, Deitcher SR "Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review." Arch Intern Med 164 (2004): 1965-76.[PMID: 15477430]
17	Product Information. Vectical (calcitriol topical). Galderma Laboratories Inc, Cranbury, NJ.
18	Product Information. Dovonex (calcipotriene). Westwood Squibb Pharmaceutical Corporation, Eatontown, NJ.
19	Jori A, Carrara MC "On the mechanism of the hyperglycaemic effect of chlorpromazine." J Pharm Pharmacol 18 (1966): 623-4. [PMID: 4381950]
20	Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
21	Product Information. Thorazine (chlorpromazine). SmithKline Beecham, Philadelphia, PA.
22	Product Information. Aromasin (exemestane) Pharmacia &amp Upjohn, Kalamazoo, MI.
23	Product Information. Femara (letrozole). Novartis Pharmaceuticals, East Hanover, NJ.
24	Product Information. Arimidex (anastrozole). Zeneca Pharmaceuticals, Wilmington, DE.
25	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
26	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
27	Legler UF, Benet LZ "Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives." Clin Pharmacol Ther 39 (1986): 425-9
28	Meffin PJ, Wing LM, Sallustio BC, Brooks PM "Alterations in prednisolone as a result of oral contraceptive use and dose." Br J Clin Pharmacol 17 (1984): 655-64
29	Frey BM, Schaad HJ, Frey FJ "Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone." Eur J Clin Pharmacol 26 (1984): 505-11
30	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
31	Arts CJM, Govers CARL, van den Berg H, Wolters MGE, van Leeuwen P, Thijssen JHH "In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs." J Steroid Biochem Mol Biol 38 (1991): 621-8. [PMID: 1645589]
32	Cerner Multum, Inc. "Canadian Product Information.".
33	Product Information. Nextstellis (drospirenone-estetrol). Mayne Pharma, Greenville, NC.
34	Product Information. Questran (cholestyramine). Par Pharmaceutical Inc, Chestnut Ridge, NY.
35	Underhill KL, Rotter BA, Thompson BK, Prelusky DB, Trenholm HL "Effectiveness of cholestyramine in the detoxification of zearalenone as determined in mice." Bull Environ Contam Toxicol 54 (1995): 128-34. [PMID: 7756775]
36	Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception.".
37	Product Information. Angeliq (drospirenone-estradiol). Berlex Laboratories, Wayne, NJ.
38	Product Information. Ortho-Est (estropipate). Ortho McNeil Pharmaceutical, Raritan, NJ.
39	Product Information. Premarin (conjugated estrogens). Wyeth-Ayerst Laboratories, Philadelphia, PA.
40	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
41	Devenport MH, Crook D, Wynn V, Lees LJ "Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives." Br J Clin Pharmacol 27 (1989): 851-9. [PMID: 2547410]
42	Lazar JD, Wilner KD "Drug interactions with fluconazole." Rev Infect Dis 12 Suppl 3 (1990): s327-33. [PMID: 2330488]
43	Pillans PI, Sparrow MJ "Pregnancy associated with a combined oral contraceptive and itraconazole." N Z Med J 106 (1993): 436. [PMID: 8414287]
44	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
45	Sinofsky FE, Pasquale SA "The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives." Am J Obstet Gynecol 178 (1998): 300-4. [PMID: 9500490]
46	Weisberg E "Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result?." Clin Pharmacokinet 36 (1999): 309-13. [PMID: 10384856]
47	Product Information. Berinert (complement C1 esterase inhibitor). CSL Behring, King of Prussia, PA.
48	Product Information. Cinryze (complement C1 esterase inhibitor). ViroPharma Incorporated, Exton, PA.
49	Product Information. Ruconest (conestat alfa). Valeant Pharmaceuticals, Costa Mesa, CA.
50	Gandhi PK, Gentry WM, Bottorff MB "Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database." Pharmacotherapy 32 (2012): 902-9. [PMID: 23033229]
51	Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
52	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
53	Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
54	Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T "Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17B-estradiol." Eur J Drug Metab Pharmacokinet 20 (1995): 219-24. [PMID: 8751044]
55	Weber A, Jager R, Borner A, et al. "Can grapefruit juice influence ethinyl estradiol bioavailability?" Contraception 53 (1996): 41-7. [PMID: 8631189]
56	Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
57	Ohman I, Vitols S, Tomson T "Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation." Epilepsia 41 (2000): 706-13
58	Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006 Feb;61(2):191-9.
59	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
60	Arafah BM "Increased need for thyroxine in women with hypothyroidism during estrogen therapy." N Engl J Med 344 (2001): 1743-9. [PMID: 11396440]
61	Chetkowski RJ, Meldrum DR, Steingold KA, et al. "Biologic effects of transdermal estradiol." N Engl J Med 314 (1986): 1615-20. [PMID: 3012339]
62	Irving S, Vadiveloo T, Leese GP "Drugs that interact with levothyroxine an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS)." Clin Endocrinol (Oxf) (2014):. [PMID: 25040647]
63	Product Information. Synthroid (levothyroxine). Abbott Pharmaceutical, Abbott Park, IL.
64	Utiger RD "Estrogen, thyroxine binding in serum, and thyroxine therapy." N Engl J Med 344 (2001): 1784-5. [PMID: 11396448]
65	Adson DE, Kotlyar M "A probable interaction between a very low-dose oral contraceptive and the antidepressant nefazodone: a case report." J Clin Psychopharmacol 21 (2001): 618-9. [PMID: 11763013]
66	Product Information. Banzel (rufinamide). Eisai Inc, Teaneck, NJ.
67	Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
68	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
69	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
70	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
71	Product Information. Depakote (divalproex sodium). Abbott Pharmaceutical, Abbott Park, IL.
72	Product Information. Depacon (valproic acid). Abbott Pharmaceutical, Abbott Park, IL.
73	Herzog AG, Farina EL, Blum AS "Serum valproate levels with oral contraceptive use." Epilepsia 46 (2005): 970-1.
74	Reimers A, Brodtkorb E, Sabers A. "Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations." Seizure. 2015;28:66-70.
75	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (second of two parts)." N Engl J Med 285 (1971): 547-58. [PMID: 4397794]
76	Ku LL, Ward CO, Durgin SJ "A clinical study of drug interaction and anticoagulant therapy." Drug Intell Clin Pharm 4 (1970): 300-6.
77	Meade TW "Oral contraceptives, clotting factors, and thrombosis." Am J Obstet Gynecol 142 (1982): 758-61. [PMID: 6801980]
78	Notelovitz M "Oral contraception and coagulation." Clin Obstet Gynecol 28 (1985): 73-83. [PMID: 3987135]
79	Schrogie JJ, Solomon HM, Zieve PD "Effect of oral contraceptives on vitamin K-dependent clotting activity." Clin Pharmacol Ther 8 (1967): 670-5. [PMID: 4167917]
80	Stangel JJ, Innerfield I, Reyniak JV, Stone ML "The effect of conjugated estrogens on coagulability in menopausal women." Obstet Gynecol 49 (1977): 314-6. [PMID: 190571]
81	von Kaulla E, Droegemueller W, von Kaulla KN "Conjugated estrogens and hypercoagulability." Am J Obstet Gynecol 122 (1975): 688-92. [PMID: 15850603]
82	Edelbroek PM, Zitman FG, Knoppert-van der Klein EA, van Putten PM, de Wolff FA "Therapeutic drug monitoring of amitriptyline: impact of age, smoking and contraceptives on drug and metabolite levels in bulimic women." Clin Chim Acta 165 (1987): 177-87. [PMID: 3652444]
83	Somani SM, Khurana RC "Mechanism of estrogen-imipramine interaction." JAMA 223 (1973): 560. [PMID: 4739153]
84	Eichling PS, Sahni J. Menopause related sleep disorders. J Clin Sleep Med. 2005 Jul 15;1(3):291-300.
85	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
86	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
87	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
88	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
89	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
90	Galbraith RA, Michnovicz JJ "The effects of cimetidine on the oxidative metabolism of estradiol." N Engl J Med 321 (1989): 269-74. [PMID: 2747769]
91	Galbraith RA, Michnovicz JJ "The oxidative metabolism of estradiol: inhibition by cimetidine." Trans Assoc Am Physicians 102 (1989): 44-54. [PMID: 2638529]
92	Michnovicz JJ, Galbraith RA "Cimetidine inhibits catechol estrogen metabolism in women." Metabolism 40 (1991): 170-4. [PMID: 1988774]
93	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
94	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
95	Product Information. Vitrase (hyaluronidase). Bausch and Lomb, Rochester, NY.
96	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
97	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence